Concepedia

Christopher Rota

CR

Statistics

Publications

4

Citations

880

H-Index

4

Active since

2014

Affiliations

Stanford University(Current)

Harvard University

University of Colorado Anschutz Medical Campus

Children's Hospital of Philadelphia

University of Virginia

Christopher Rota is an author at Stanford University specializing in oncology, car t cell trials, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2014–2024

4

Publications

4

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

Robbie G. Majzner, Johanna Theruvath, Anandani Nellan et al. · Clinical Cancer Research · 2019 · 672 citations · Full text

, , +15

Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells

Anandani Nellan, Christopher Rota, Robbie G. Majzner et al. · Journal for ImmunoTherapy of Cancer · 2018 · 136 citations · Full text

, , +17

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke et al. · Cancer Cell · 2024 · 49 citations · Full text

, , +17

<i>Drosophila</i> FANCM Helicase Prevents Spontaneous Mitotic Crossovers Generated by the MUS81 and SLX1 Nucleases

Hung‐Che Kuo, Susan McMahan, Christopher Rota et al. · Genetics · 2014 · 23 citations · Full text

, , +15

1–4 of 4